Sector › Medicine

Press Releases

New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease

Jul 31, 2025 08:20 HKT/SGT

Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025

Jul 31, 2025 08:10 HKT/SGT

Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

Jul 29, 2025 16:00 HKT/SGT

LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma

Jul 29, 2025 08:01 HKT/SGT

GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果

Jul 29, 2025 08:00 HKT/SGT

GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果

Jul 29, 2025 08:00 HKT/SGT

China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China

Jul 29, 2025 05:00 JST

China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China

Jul 29, 2025 04:00 HKT/SGT

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases

Jul 28, 2025 20:00 HKT/SGT

KKR、トプコンに対する公開買付けを開始

Jul 28, 2025 19:30 JST

維立志博於聯交所主板成功上市

Jul 25, 2025 19:36 HKT/SGT

维立志博于联交所主板成功上市

Jul 25, 2025 18:00 HKT/SGT

Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics

Jul 25, 2025 16:00 JST

Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics

Jul 25, 2025 15:00 HKT/SGT

Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China

Jul 25, 2025 11:52 JST

Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million

Jul 25, 2025 11:01 JST

億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市

Jul 25, 2025 10:52 HKT/SGT

亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市

Jul 25, 2025 10:52 HKT/SGT

Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China

Jul 25, 2025 10:52 HKT/SGT

云顶新耀宣布配售股份拟集资约15.725亿港元

Jul 25, 2025 10:01 HKT/SGT